Early viral dynamics in HCV-RNA decay and NS3-resistance development predict the risk of failure to first-generation protease inhibitors
Valeria Cento(Rostov State Medical University), Francesca Ceccherini‐Silberstein(University of Cologne), Andrea De Maria(Ospedale Policlinico San Martino), Marco Massari(Azienda Sanitaria Unità Locale di Reggio Emilia), Alessandra Mangia(Casa Sollievo della Sofferenza), Adriano Pellicelli(Carlo Forlanini Hospital), Giuliano Rizzardini, Laura Ambra Nicolini(Ospedale Policlinico San Martino), Tamara Ursini(Ospedale Sacro Cuore Don Calabria), M. Siciliano, F. De Leonardis(University of Rome Tor Vergata), Simona Landonio(ASST Fatebenefratelli Sacco), Claudio Maria Mastroianni(Sapienza University of Rome), Antonio Gasbarrini(Università Cattolica del Sacro Cuore), M. Aragri(University of Rome Tor Vergata), A. Picciotto(Fondazione Bruno Kessler), Annalisa Tortora(Università Cattolica del Sacro Cuore), Monica Tontodonati(Azienda USL di Pescara), Sergio Babudieri(University of Sassari), S. Francioso, Ada Bertoli(IRCCS Policlinico San Donato), Ilaria Lenci, Ennio Polilli(Azienda USL di Pescara), Ivana Maida, A. Manunta(University of Sassari), Gloria Taliani(Sapienza University of Rome), Alessandro Mancon(Luigi Sacco Hospital), M. Angélico, Massimo Andreoni(University of Rome Tor Vergata), F.P. Antonucci(University of Rome Tor Vergata), Velia Chiara Di Maio(University of Rome Tor Vergata), L. Nosotti, Giustino Parruti(Azienda USL di Pescara), Valeria Micheli(ASST Fatebenefratelli Sacco), Stefano Marenco(National Institutes of Health), Jacopo Vecchiet(University of Chieti-Pescara), Carlo Federico Perno(Centre International De Reference Chantal Biya), Daniele Di Paolo(University of Rome Tor Vergata), M.S. Mura(University of Sassari), Claudio Viscoli(Radboud University Nijmegen), C. Magni(ASST Fatebenefratelli Sacco), C. Sarrecchia(University of Rome Tor Vergata), F. Niero(University of Milan), Antonio Di Biagio
Cited by 0
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998